Skip to content

Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome

Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02649413
Acronym
AJSNS
Enrollment
75
Registered
2016-01-07
Start date
2016-03-31
Completion date
2019-06-30
Last updated
2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome, Minimal Change

Brief summary

The initial steroids dose for Nephrotic Syndrome is 60mg/1m2 for 6-4 weeks and the duration of the first steroid course is between 8 weeks to 6 months. The base of the initial dose for steroids Idiopathic nephrotic syndrome been put in the early 70s. In our study the investigators will adjusted the first steroids does to the response day. Our primary end point is : a lower adjusted dose is as good as the fix dose in the first year after diagnosis.

Detailed description

About 90% of the patients will response to steroid therapy. The initial steroid dose is between 2mg/kg or 60mg/1m2 for 6-4 weeks and the duration of the first steroid course is between 8 weeks to 6 months. The bases of this treatment have been put in the early 70s. Since then most of the study were focused on the duration of the therapy with a results that 8-12 weeks course is as good as 6 month. Studies have showed no difference in response rate between 2mg/kg to 60m2' although the difference in the dose in young children can rich to 25%. Other retrospective analysis been show that patients who response in the first 7-9 days tend to have lass relapses than other patients. In our nephrology clinic the investigators there is ongoing clinical study on low doses of steroid therapy for relapse of nephritic syndrome with good results.

Interventions

DRUGPrednisone

Children with Idiopathic Nephrotic syndrome will start 60 mg/m2 prednisone.children that response in 8 days will receive an adjusted dose while the rest of the group will receive the 4 weeks usually dose.

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children who recently have been diagnosed with nephrotic syndrome.

Exclusion criteria

* Children with nephrotic syndrome that can not be treated with steroids.

Design outcomes

Primary

MeasureTime frameDescription
The time until the first relapse6 monthsAll Children with Nephrotic Syndrome will start a dose of 60 mg/m2 prednisone.patients that will response in 8 days (the first day with a negative or trace in the urine deep stick test)will receive adjusted lower steroid dose.the outcome is the time until the first relapse( positive protein in deep stick urine test,or low serum albumin with positive urine deep stick).the control group is the historical data from a prospective malty center observation study.

Secondary

MeasureTime frameDescription
Number of relapse during first yearone yearWe will count the number of relapse episodes in the first year since diagnosis.

Countries

Israel

Contacts

Primary ContactAmit Dagan, Dr.
DaganA@clalit.org.il9723-9253979
Backup ContactAmit Dagan, Dr.
DaganA@clalit.org.il972-925379

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026